Shares of Ajanta Pharma were trading at Rs 2,658.50 in today's session, up by 0.46% from the previous close. The stock experienced high volume during the trading session, placing it among the actively traded stocks on the Nifty Midcap 150.
Ajanta Pharma's revenue for the quarter ending March 2025 stood at Rs 1,170.41 Crore, compared to Rs 1,054.08 Crore for the quarter ending March 2024. The net profit for the same period was Rs 225.26 Crore, up from Rs 202.72 Crore in the previous year. The EPS stood at Rs 18.00 for the quarter ending March 2025, compared to Rs 16.10 for the quarter ending March 2024.
Here's a summary of Ajanta Pharma's quarterly financial performance:
| Heading | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 1,054.08 Crore | Rs 1,144.92 Crore | Rs 1,186.64 Crore | Rs 1,146.13 Crore | Rs 1,170.41 Crore |
| Net Profit | Rs 202.72 Crore | Rs 245.77 Crore | Rs 216.48 Crore | Rs 232.88 Crore | Rs 225.26 Crore |
| EPS | 16.10 | 19.54 | 17.27 | 18.60 | 18.00 |
The annual consolidated financial performance shows growth. Revenue for the year ending March 2025 reached Rs 4,648.10 Crore, compared to Rs 4,208.71 Crore for the year ending March 2024. The net profit also increased, from Rs 816.17 Crore for the year ending March 2024 to Rs 920.39 Crore for the year ending March 2025. EPS increased to Rs 73.56 in March 2025 compared to Rs 64.82 in March 2024.
Here's a more detailed look at the annual financials:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,889.69 Crore | Rs 3,340.99 Crore | Rs 3,742.64 Crore | Rs 4,208.71 Crore | Rs 4,648.10 Crore |
| Net Profit | Rs 653.87 Crore | Rs 712.68 Crore | Rs 587.98 Crore | Rs 816.17 Crore | Rs 920.39 Crore |
| EPS | 75.09 | 82.45 | 45.89 | 64.82 | 73.56 |
| BVPS | 344.52 | 380.24 | 268.14 | 282.34 | 302.38 |
| ROE | 21.82 | 21.83 | 17.35 | 22.87 | 24.28 |
| Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ajanta Pharma's financial performance is reflected in both its quarterly and annual results. The company’s revenue, net profit, and EPS have shown steady growth. The revenue has increased by 10.44% from Rs 4,208.71 Crore in 2024 to Rs 4,648.10 Crore in 2025. The net profit has increased by 12.77% from Rs 816.17 Crore in 2024 to Rs 920.39 Crore in 2025.
Ajanta Pharma announced an interim dividend of Rs 28 per share on October 25, 2024, with an effective date of November 6, 2024. Additionally, a bonus issue was announced on May 10, 2022, with a ratio of 1:2 and an ex-bonus date of June 22, 2022. The company also underwent a stock split, with the old face value of Rs 5 being split to a new face value of Rs 2; the ex-split date was March 20, 2015.
With the stock currently trading at Rs 2,658.50, Ajanta Pharma is showing a marginal gain amid high volume during today's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
